Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial
Mark Y Chan1, Jie L Sun, L Kristin Newby
1MBBS, MHS, National University Heart Center, 5 Lower Kent Ridge Road, Singapore, Singapore 119074. chanyymark@gmail.com
Circulation
|June 10, 2009
Summary
ST-segment elevation myocardial infarction (STEMI) carries higher short-term mortality risk, while non-STEMI (NSTEMI) presents greater long-term mortality risk. Early revascularization improves outcomes for both STEMI and NSTEMI patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Limited contemporary data exist comparing long-term outcomes after cardiac catheterization for ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI).
- Understanding differential risks and benefits of interventions is crucial for acute myocardial infarction (AMI) management.
Purpose of the Study:
- To compare long-term mortality rates between STEMI and NSTEMI patients undergoing cardiac catheterization.
- To evaluate the impact of early revascularization on mortality in STEMI versus NSTEMI patients.
Main Methods:
- Retrospective analysis of 4387 patients with significant coronary lesions undergoing cardiac catheterization (1999-2005).
- Comparison of adjusted mortality rates over time using piece-wise analysis.
- Stratified analysis of early revascularization's effect on mortality in STEMI and NSTEMI cohorts.
Main Results:
- STEMI patients exhibited higher adjusted short-term mortality risk (first 2 months) compared to NSTEMI.
- NSTEMI patients demonstrated a lower adjusted long-term mortality risk after 2 months.
- Early revascularization was associated with reduced adjusted mortality risk in both STEMI and NSTEMI groups, with no significant interaction.
Conclusions:
- STEMI is linked to higher short-term mortality, whereas NSTEMI is associated with increased long-term mortality in acute MI patients with coronary disease.
- Early revascularization offers comparable long-term survival benefits for both STEMI and NSTEMI.
- Extended follow-up is recommended for clinical trials investigating early revascularization in NSTEMI to detect treatment benefits.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...